32-week, multicentre, open, randomised, two-way cross-over, clinical trial comparing insulin glargine (HOE 901) in combination with insulin lispro and neutral protamine Hagedorn in combination with regular human insulin in subjects with type one diabetes mellitus on a meal-time and basal insulin regimen

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2007
This article has no abstract
Epistemonikos ID: a97d291b618068a30cce00613ff3305dc780ddd1
First added on: Jan 17, 2025